Treatment of heart failure with autologous skeletal myoblasts

Chachques, J. (J.); Cattadori, B. (B.); Herreros, J. (Jesús); Prosper-Cardoso, F. (Felipe); Trainini, J. (Jorge); Blanchard, D. (D.); Fabiani, J.N. (J.N.); Carpentier, A. (A.)

Authors:

Chachques, J. (J.)

Cattadori, B. (B.)

Herreros, J. (Jesús)

Prosper-Cardoso, F. (Felipe)

Keywords:

Materias Investigacion::Ciencias de la Salud::Microbiología y biología molecular
Cellular biology
Myoblasts
Cellular cardiomyoplsty
Cell trasplantation
Myocardial infarction
Congestive hearth failure

Issue Date:

2002

Publisher:

Springer

Publisher Version:

The original publication is available at www.springerlink.com http://www.springerlink.com/content/4hkqecr4erq3tkjt/

ISSN:

0340-9937

Citation:

Chachques, J. C., Cattadori, B.,Herreros, J., Prosper, F., Trainini, J. C., Blanchard, D. et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002; 27: 570–8

Abstract

The management of patients with heart failure is a daily challenge for cardiologists and cardiac surgeons. Pharmacotherapy, atrio-biventricular resynchronization, myocardial revascularization, valve repair techniques, latissimus dorsi cardiomyoplasty, acorn cardiac support device, heart transplantation and mechanical assist devices do not cover all the needs. The recent progress in cellular and molecular biology allows the development of new therapies for heart failure. Transplantation of Autologous Cells: One of the most innovative consists in the transplantation of autologous ex-vivo expanded cells into the myocardium for heart muscle regeneration. This approach is called “cellular cardiomyoplasty”.

URI:

https://hdl.handle.net/10171/17233

Appears in Collections:

DA - CIMA - Hemato-oncología - Síndromes mieloproliferativos - Artículos de Revista
DA - CIMA - Medicina regenerativa - Terapia celular - Artículos de Revista
DA - CUN - Área de Terapia Celular - Artículos de revista

Files in This Item: